Latest Blogs

Jan 19, 2023
Dr. Kathryn DeCarli and Dr. Jonathan Marron consider the actions an oncologist must, ought, and should take when offering professional medical interpretation services to a patient.
Dec 08, 2022
ASCO’s delegation to the American Medical Association’s House of Delegates (AMA HOD) recently traveled to Honolulu for the Interim meeting. Our resolutions primarily focused on the threat of legislation that could criminalize medically necessary care in the wake of the Supreme Court’s decision...
Dec 07, 2022
“Sitting here now, at 51 years old and as a cancer survivor of five years, the importance of self-care has become quite clear to me," writes Dr. Doug Flora.
Nov 28, 2022
I began my medical career in Arizona, where I received an early lesson in the importance of cultural sensitivity thanks to members of the Navajo Nation from the Four Corners region.
Subscribe to this column

Daniel F. Hayes, MD, FASCO, FACP

Daniel F. Hayes, MD, FACP, FASCO, is a Professor of Internal Medicine, the Stuart B. Padnos Professor in Breast Cancer, and the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center. An ASCO member since 1986, Dr. Hayes has served the Society in numerous volunteer capacities, including as 2016-2017 ASCO President. He is involved in several ASCO Expert Panels related to breast cancer. He served on the ASCO Board of Directors from 2011-2014, on the Conquer Cancer Foundation Grants Selection Committee, as Chair of the Scientific Program Committee, and on the Journal of Clinical Oncology Editorial Board. In 2007, he was presented with ASCO’s Gianni Bonadonna Breast Cancer Award and Lecture; in 2013, he was elected as a Fellow of ASCO (FASCO). Follow Dr. Hayes on Twitter @hoosierdfh.

Nov 28, 2016
Policy issues fundamentally affect us, our practices, and most importantly, our patients. As I hope you are aware, ASCO has our backs.  Indeed, understanding and making meaningful changes to health policy has become a major focus of ASCO.  
Oct 25, 2016
“When are we going to cure cancer?” If I had a dime for every time I’ve been asked that...The trite answer is that we already cure many cancers, just not enough of them! But the real question should be, “Why don’t we cure all cancers?”
Oct 18, 2016
Vice President Joe Biden and the government-wide Cancer Moonshot Task Force have presented today a sweeping vision that, if realized, could change the face of cancer prevention, screening, treatment, and survivorship as we know it.
Aug 24, 2016
Support for federal research funding for cancer is not about politics. It's about people. There is no one in our society—liberal, conservative, libertarian, or just don’t care—who isn’t touched in some way by cancer.
Jul 11, 2016
Believe it or not, the Medicare Access and CHIP Reauthorization Act of 2015 was passed more than 1 year ago, and program changes begin in less than six months, on Janurary 1, 2017.
Jun 13, 2016
Last week I introduced the theme I’ve selected for my term as ASCO President, Together, we’ll be making a difference for our patients and in our profession with the help of some game-changing initiatives from ASCO, of which I will describe just a few.

Pages